Market Tracker

12/19 11:01pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7399
Data as of Dec 19
 +0.0199 / +2.76%
Today’s Change
0.43
Today|||52-Week Range
1.85
+45.08%
Year-to-Date

Today’s Trading

Previous close0.72
Today’s open0.72
Day’s range0.71 - 0.74
Volume832,881
Average volume (3 months)888,304
Market cap$131.9M
Dividend yield--
Data as of 4:03pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-57.14%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.60

Competitors

 Today’s
change
Today’s
% change
ELTPElite Pharmaceutical...-0.00-0.91%
MDWDMediwound Ltd-0.15-2.40%
MSLIMerus Labs Internati...+0.27+19.57%
GTXIGTX Inc-0.08-8.25%
Data as of 3:59pm ET, 12/19/2014

Financials

Last reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts